Ascendis Pharma A/S (NASDAQ:ASND – Free Report) had its price target reduced by Oppenheimer from $190.00 to $180.00 in a research note published on Friday,Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. A number of other research firms have also recently issued reports on ASND. Evercore ISI boosted their price […]

Femasys (NASDAQ:FEMY – Get Free Report) had its target price lowered by stock analysts at Chardan Capital from $10.00 to $8.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Separately, HC Wainwright restated a “buy” rating and set a $12.00 price objective on shares of […]

Exact Sciences (NASDAQ:EXAS – Free Report) had its price target cut by Piper Sandler from $85.00 to $75.00 in a report published on Monday,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. Several other brokerages have also recently issued reports on EXAS. Canaccord Genuity Group lowered their target price on […]

Monster Beverage (NASDAQ:MNST – Free Report) had its price objective decreased by Deutsche Bank Aktiengesellschaft from $61.00 to $59.00 in a research report report published on Friday, MarketBeat Ratings reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock. Other analysts have also recently issued research reports about the company. UBS Group lifted […]

89bio (NASDAQ:ETNB – Free Report) had its target price lowered by Raymond James from $53.00 to $49.00 in a report published on Friday morning,Benzinga reports. Raymond James currently has a strong-buy rating on the stock. Several other brokerages also recently commented on ETNB. HC Wainwright restated a “buy” rating and issued a $29.00 target price […]

Enphase Energy (NASDAQ:ENPH – Get Free Report) had its price objective reduced by Bank of America from $72.00 to $62.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an “underperform” rating on the semiconductor company’s stock. Bank of America‘s price objective indicates a potential downside of 7.32% from the stock’s current price. […]